ID   VMM39
AC   CVCL_A739
DR   BTO; BTO_0005447
DR   ATCC; CRL-3230
DR   ChEMBL-Cells; CHEMBL4483141
DR   ChEMBL-Targets; CHEMBL4483275
DR   Cosmic; 890888
DR   Cosmic; 1054848
DR   Cosmic; 1507601
DR   Cosmic; 2233683
DR   GEO; GSM1572823
DR   GEO; GSM1572824
DR   GEO; GSM1572825
DR   GEO; GSM1572826
DR   GEO; GSM1572827
DR   GEO; GSM1572828
DR   GEO; GSM1671975
DR   GEO; GSM1672000
DR   GEO; GSM1672042
DR   GEO; GSM1672069
DR   GEO; GSM1672087
DR   GEO; GSM1672091
DR   GEO; GSM1672111
DR   GEO; GSM1672121
DR   GEO; GSM1672128
DR   PubChem_Cell_line; CVCL_A739
DR   Wikidata; Q54993268
RX   PubMed=14871852;
RX   PubMed=17308088;
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3230
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 7,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan K.T., Coppola M.A., Gatlin C.L., Thompson L.W., Shabanowitz J.,
RA   Hunt D.F., Engelhard V.H., Ross M.M., Slingluff C.L. Jr.;
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//
RX   PubMed=17308088; DOI=10.1158/0008-5472.CAN-06-3311;
RA   Shields J.M., Thomas N.E., Cregger M., Berger A.J., Leslie M.,
RA   Torrice C., Hao H.-L., Penland S., Arbiser J.L., Scott G.A., Zhou T.,
RA   Bar-Eli M., Bear J.E., Der C.J., Kaufmann W.K., Rimm D.L.,
RA   Sharpless N.E.;
RT   "Lack of extracellular signal-regulated kinase mitogen-activated
RT   protein kinase signaling shows a new type of melanoma.";
RL   Cancer Res. 67:1502-1512(2007).
//
RX   PubMed=20856146; DOI=10.1097/CMR.0b013e32833fafb4; PMCID=PMC3229868;
RA   Mikesh L.M., Kumar M., Erdag G., Hogan K.T., Molhoek K.R., Mayo M.W.,
RA   Slingluff C.L. Jr.;
RT   "Evaluation of molecular markers of mesenchymal phenotype in
RT   melanoma.";
RL   Melanoma Res. 20:485-495(2010).
//
RX   PubMed=21654344; DOI=10.1097/CMR.0b013e328343a1d6; PMCID=PMC3131461;
RA   Molhoek K.R., Shada A.L., Smolkin M., Chowbina S., Papin J.,
RA   Brautigan D.L., Slingluff C.L. Jr.;
RT   "Comprehensive analysis of receptor tyrosine kinase activation in
RT   human melanomas reveals autocrine signaling through IGF-1R.";
RL   Melanoma Res. 21:274-284(2011).
//